Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations

By Ramachandran S. Vasan. Circulation, 2006

1,230 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Immunology, Surgery

View Paper: https://www.semanticscholar.org/paper/1c55afa1a4b17fc0d353b944f8d8796e3fdf0d3b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Peter Libby
2. G. Hansson
3. P. Ridker
4. Michael F. O'Rourke
5. J. Hashimoto
6. L. Melvin
7. A. Lichtman
8. I. Tabas

In Immunology

1. Peter Libby
2. P. Ridker
3. G. Hansson
4. Michael F. O'Rourke
5. J. Hashimoto
6. I. Tabas
7. Jongsoon Lee
8. Byung-Cheol Lee

In Surgery

1. Peter Libby
2. G. Hansson
3. P. Ridker
4. Michael F. O'Rourke
5. Christian K. Roberts
6. J. Hashimoto
7. I. Tabas
8. L. Melvin

Citations in the corpus

• Mechanical factors in arterial aging: a clinical perspective. (2007, background): “This easure is incorporated in Framingham and National Intitute of Aging studies (7).”
• Effects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2015, background): “Although the exact biological mechanisms are not clear, our findings indicate that exercise may exert cardioprotective effects by altering dyslipidemia, inflammation, insulin resistance, and hemostasis.(19) As a major component of HDL, apolipoprotein A1 plays an important role in the cardioprotectiv”
• Effect of lower sodium intake on health: systematic review and meta-analyses (2013, background): “Blood pressure is recognised as a reliable biomarker for estimating risk of cardiovascular disease 126 127 because of the well established causal relation between increasing blood pressure and increasing risk of cardiovascular diseases, especially coronary heart disease and stroke.”
• Inflammation in Atherosclerosis: From Pathophysiology to Practice (2009, background): “(42) Among the many biomarkers of inflammation proposed for diagnostic use, myeloperoxidase, lipoprotein-associated phospholipase A2 (Lp-PLA2), pentraxin-3, cytokines such as IL-6, proteases such as matrix metalloproteinase 9, and C-reactive protein (CRP) measured by a highly sensitive assay (hs-CRP”
• Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype (2012, background): “95 percentile of healthy non-smokers were considered abnormal [26,27] (Table S3).”